Alignment Healthcare (NASDAQ:ALHC) Director Sells $425,000.00 in Stock

Key Points

• Director Joseph Konowiecki sold 25,000 shares of Alignment Healthcare at an average price of $17.00, amounting to a total of $425,000, reducing his ownership by 2.17%.
• Alignment Healthcare reported a quarterly revenue of $1.02 billion, exceeding analysts' expectations and reflecting a 49% year-over-year growth.
• Recent analyst upgrades have led to varied ratings for Alignment Healthcare, with Barclays moving to an "equal weight" and KeyCorp raising to "overweight" with a target price of $21.00.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) Director Joseph S. Konowiecki sold 25,000 shares of the stock in a transaction dated Tuesday, September 9th. The shares were sold at an average price of $17.00, for a total transaction of $425,000.00. Following the completion of the transaction, the director owned 1,127,049 shares of the company's stock, valued at $19,159,833. This represents a 2.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alignment Healthcare Price Performance

Shares of ALHC traded up $0.28 during trading hours on Monday, reaching $16.32. The company had a trading volume of 4,336,879 shares, compared to its average volume of 3,638,717. The firm has a 50 day simple moving average of $14.47 and a 200-day simple moving average of $15.54. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market capitalization of $3.23 billion, a price-to-earnings ratio of -58.28 and a beta of 1.17. Alignment Healthcare, Inc. has a 12-month low of $9.15 and a 12-month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's revenue was up 49.0% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.13) EPS. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds have recently modified their holdings of the company. MCF Advisors LLC boosted its stake in shares of Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Alignment Healthcare during the 1st quarter worth about $42,000. SBI Securities Co. Ltd. boosted its stake in shares of Alignment Healthcare by 4,868.9% during the 2nd quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company's stock worth $42,000 after purchasing an additional 2,970 shares during the last quarter. KBC Group NV acquired a new stake in shares of Alignment Healthcare during the 2nd quarter worth about $44,000. Finally, Signaturefd LLC boosted its stake in shares of Alignment Healthcare by 142.6% during the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company's stock worth $53,000 after purchasing an additional 2,215 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ALHC has been the subject of several recent research reports. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $9.00 to $13.00 in a report on Thursday, July 31st. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price for the company in a report on Monday, August 25th. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a report on Friday, August 8th. Wall Street Zen downgraded shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a report on Sunday, August 10th. Finally, Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, Alignment Healthcare has an average rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.